You are the profession. Have your say.™

blog posts

  • Glittering prizes for vets at the BSAVA Congress 2009

    Noel Fitzpatrick

    BSAVA Congress 2009 saw awards presented to vets from many different disciplines within the profession.…

    By: John Bonner
    Published: 08 Apr 2009
    0 Comments
  • PFMA confirms extent of obesity epidemic in British pets

    PFMA report

    Government statistics show that human obesity has reached crisis point, with around two-thirds of people living in Britain either overweight or obese. The problem extends to our pets, one in three household pets is now overweight, which equates to a stagg…

    By: David Watson
    Published: 26 Mar 2009
    0 Comments
  • ITV ‘Tonight' programme signals time for vets to stop the rot?

    ITV Tonight

    The ITV ‘Tonight' programme, broadcast on Monday night (16 March), sought to mount an exposė of the profession's alleged money-grabbing tactics by taking three healthy animals to a number of vets in an undisclosed area of the UK. The animals were presente…

    By: Ross Tiffin
    Published: 19 Mar 2009
    0 Comments
  • Highland equine practice scoops new prize at VMA awards

    VMA

    Kessock Equine Vets, from Inverness, are the first-ever recipients of the Practice Marketing Award, sponsored by Pfizer and which was presented at the Veterinary Marketing Association (VMA) annual luncheon extravaganza on Friday 13 March.…

    By: David Watson
    Published: 18 Mar 2009
    0 Comments
  • ITV programme ‘Pets Undercover': SPVS comment

    spvsRGBversion

    The Society of Practising Veterinary Surgeons (SPVS) does not agree with the programme's central thrust of overcharging and unnecessary treatment and would agree with the statement made by the featured vet, Mark Abraham, that "the vast majority of vets pr…

    By: David Watson
    Published: 18 Mar 2009
    0 Comments
  • Roche and Genentech reach 'friendly' agreement

    Genentech logo

    Swiss pharmaceutical giant, Roche, has agreed to merge with specialist US cancer drug producing company, Genentech, and will buy remaining shares for £34 billion.…

    By: Ross Tiffin
    Published: 16 Mar 2009
    0 Comments